Molecular Traffic Signal Could Be A New HIV Drug Target
NIAID And VaxGen, Inc. Collaborate On AIDS vaccine Studies
NIAID Announces Funding For 12 Centers For AIDS Research (CFAR)
Success in Implementing Public Health Service Guidelines
New Findings Help Explain "Rebound" of HIV in Patients
Adherence To HIV Therapies --A Multidisciplinary Approach
Clinton Administration Awards $39 Million For Outpatient HIV/AIDS Services
Canadian Investigation Into Blood Tainted With HIV And Hep C Virus Continues
Animal Virus Controls HIV Infection
Just Released! Two New NIH Draft Documents Addressing Latest HIV Treatment
Draft Report To Be Made Available On Dietary Supplement Labels
Draft HIV/AIDS Treatment Guidelines
FDA Approves First Protease Inhibitors For Children: Viracept® & Norvir®
825 Abstracts from the 4th Conference on Retroviruses and Opportunistic Infections
|
ADDITIONAL RESOURCES:
|